CO5611196A2 - Derivados de quinolina - Google Patents

Derivados de quinolina

Info

Publication number
CO5611196A2
CO5611196A2 CO04091781A CO04091781A CO5611196A2 CO 5611196 A2 CO5611196 A2 CO 5611196A2 CO 04091781 A CO04091781 A CO 04091781A CO 04091781 A CO04091781 A CO 04091781A CO 5611196 A2 CO5611196 A2 CO 5611196A2
Authority
CO
Colombia
Prior art keywords
quinoline derivatives
formula
racemic
alkyl
compound
Prior art date
Application number
CO04091781A
Other languages
English (en)
Inventor
Peter Gull
Villar Esteban Pombo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5611196A2 publication Critical patent/CO5611196A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1.- Un compuesto de la fórmula la: en donde A y Q son cada uno H o forman juntos un enlace adicional, y en donde el centro asimétrico en la posición 3 puede ser racémico, o puede estar en una forma ópticamente activa, y en donde R es de la fórmula lb ó Ic:y en donde R1 es alquilo, en forma de base libre o de sal de adición de ácido.
CO04091781A 2002-03-07 2004-09-15 Derivados de quinolina CO5611196A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02005117 2002-03-07
EP02005115 2002-03-07

Publications (1)

Publication Number Publication Date
CO5611196A2 true CO5611196A2 (es) 2006-02-28

Family

ID=27790094

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04091781A CO5611196A2 (es) 2002-03-07 2004-09-15 Derivados de quinolina

Country Status (29)

Country Link
US (2) US7399768B2 (es)
EP (1) EP1480970B1 (es)
JP (2) JP2005519117A (es)
KR (1) KR101027977B1 (es)
CN (2) CN1939915A (es)
AR (1) AR038730A1 (es)
AU (1) AU2003219023B2 (es)
BR (1) BR0308201A (es)
CA (2) CA2477720C (es)
CO (1) CO5611196A2 (es)
CY (1) CY1106409T1 (es)
DE (1) DE60311233T2 (es)
DK (1) DK1480970T3 (es)
EC (1) ECSP045271A (es)
EG (1) EG24415A (es)
ES (1) ES2279100T3 (es)
HK (1) HK1071364A1 (es)
IL (1) IL163769A0 (es)
MX (1) MXPA04008666A (es)
MY (1) MY134325A (es)
NO (1) NO20044117L (es)
NZ (1) NZ534732A (es)
PE (1) PE20030927A1 (es)
PL (2) PL215012B1 (es)
PT (1) PT1480970E (es)
RU (1) RU2345991C2 (es)
SI (1) SI1480970T1 (es)
TW (1) TW200406401A (es)
WO (1) WO2003074511A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757601B1 (en) * 2002-03-07 2009-08-05 Novartis AG Quinoline derivatives and their use in glaucoma and myopia
US10729710B2 (en) 2017-11-24 2020-08-04 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100555A (en) * 1991-02-07 2000-08-31 Hoechst Marion Roussel Inc N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
GB9326010D0 (en) * 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them
PE20030240A1 (es) * 2001-07-09 2003-04-16 Novartis Ag DERIVADOS DE BENZO [g] QUINOLINA

Also Published As

Publication number Publication date
HK1071364A1 (en) 2005-07-15
EP1480970B1 (en) 2007-01-17
ES2279100T3 (es) 2007-08-16
IL163769A0 (en) 2005-12-18
ECSP045271A (es) 2004-10-26
CN1639148A (zh) 2005-07-13
AU2003219023A1 (en) 2003-09-16
PT1480970E (pt) 2007-03-30
KR101027977B1 (ko) 2011-04-13
CN1939915A (zh) 2007-04-04
PL370915A1 (en) 2005-06-13
MXPA04008666A (es) 2004-12-06
US20080255176A1 (en) 2008-10-16
SI1480970T1 (sl) 2007-06-30
US7399768B2 (en) 2008-07-15
TW200406401A (en) 2004-05-01
AU2003219023B2 (en) 2006-11-30
PL210336B1 (pl) 2012-01-31
PL394208A1 (pl) 2011-08-16
BR0308201A (pt) 2005-01-04
DE60311233T2 (de) 2007-11-15
DK1480970T3 (da) 2007-03-05
CA2477720A1 (en) 2003-09-12
RU2345991C2 (ru) 2009-02-10
RU2004129767A (ru) 2005-06-27
US20050234085A1 (en) 2005-10-20
EP1480970A1 (en) 2004-12-01
JP2010095550A (ja) 2010-04-30
WO2003074511A1 (en) 2003-09-12
CA2706618A1 (en) 2003-09-12
PE20030927A1 (es) 2003-12-26
CA2477720C (en) 2010-09-21
JP2005519117A (ja) 2005-06-30
DE60311233D1 (de) 2007-03-08
EG24415A (en) 2009-05-25
PL215012B1 (pl) 2013-10-31
NO20044117L (no) 2004-09-28
KR20040089615A (ko) 2004-10-21
CN1293070C (zh) 2007-01-03
CY1106409T1 (el) 2011-10-12
AR038730A1 (es) 2005-01-26
NZ534732A (en) 2006-05-26
MY134325A (en) 2007-12-31

Similar Documents

Publication Publication Date Title
GT200000167A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas.
CO5590929A2 (es) Derivados de acetileno que tienen actividad antagonica de mgiur5
PE20040645A1 (es) Derivados de indolinfenilsulfonamida
SI1748985T1 (sl) Ciklični amidni derivati in njihova poizvodnja in uporaba kot antitrombotična sredstva
ATE442364T1 (de) Kristalline form von linezolid
EA200501477A1 (ru) Производные пиперидинил- и пиперазинилалкилкарбаматов, способы их получения и применение их в терапии
PE20100093A1 (es) Derivados de acetileno
AR034985A1 (es) Compuesto biciclico; produccion y uso del mismo
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
AR049699A1 (es) Derivados de pirimidina
RS53543B1 (en) NEW HYDROXY-6-HETEROARYLPHENANTRIDINES AND THEIR USE AS PDE4 INHIBITORS
CO5611143A2 (es) Profarmacos de fosfatos de fluorooxindoles
AR052915A1 (es) Derivados de pirrolidin y piperidin acetileno
PE20040696A1 (es) Derivados de acido mandelico como inhibidores de la formacion de factores de coagulacion
AR053109A1 (es) DERIVADOS DE PIPERIDINA Y PIPERAZINA, UN METODO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO EN LA ELABORACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR EL RECEPTOR DE QUIMIOQUINA CCR2.
AR011913A1 (es) Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
CO5631438A2 (es) Profarmacos de aminoacidos excitadores
ATE346121T1 (de) Rylenfarbstoffe
ATE469896T1 (de) Aminosäuresalze von rosiglitazon
CO5611196A2 (es) Derivados de quinolina
SE0101579D0 (sv) New compounds
AR055420A1 (es) Derivados de pirimidina sustituidos
MA29416B1 (fr) Inhibiteurs d'age
CO4990934A1 (es) Derivados de tiazol
EA200501226A1 (ru) Новая кристаллическая модификация негидратированного боскалида

Legal Events

Date Code Title Description
FC Application refused